Slow Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.84M | Buy |
9,640
+1,579
| +20% | +$758K | 0.56% | 64 |
|
|
2026
Q1 | $3.96M | Buy |
8,061
+670
| +9% | +$364K | 0.51% | 63 |
|
|
2025
Q4 | $4.28M | Buy |
7,391
+39
| +0.5% | +$22.1K | 0.51% | 59 |
|
|
2025
Q3 | $3.57M | Sell |
7,352
-90
| -1% | -$41.9K | 0.42% | 70 |
|
|
2025
Q2 | $3.02M | Buy |
7,442
+112
| +2% | +$46.8K | 0.37% | 78 |
|
|
2025
Q1 | $3.65M | Sell |
7,330
-117
| -2% | -$63.4K | 0.49% | 60 |
|
|
2024
Q4 | $3.88M | Sell |
7,447
-73
| -1% | -$40.1K | 0.55% | 52 |
|
|
2024
Q3 | $4.65M | Buy |
7,520
+274
| +4% | +$162K | 0.71% | 39 |
|
|
2024
Q2 | $4.01M | Sell |
7,246
-94
| -1% | -$53.9K | 0.65% | 43 |
|
|
2024
Q1 | $4.27M | Sell |
7,340
-375
| -5% | -$210K | 0.68% | 42 |
|
|
2023
Q4 | $4.1M | Buy |
7,715
+21
| +0.3% | +$10.2K | 0.71% | 39 |
|
|
2023
Q3 | $3.9M | Buy |
7,694
+425
| +6% | +$226K | 0.72% | 33 |
|
|
2023
Q2 | $3.79M | Sell |
7,269
-133
| -2% | -$71.8K | 0.66% | 38 |
|
|
2023
Q1 | $4.27M | Buy |
7,402
+1,373
| +23% | +$774K | 0.8% | 31 |
|
|
2022
Q4 | $3.32M | Sell |
6,029
-48
| -0.8% | -$25.4K | 0.74% | 37 |
|
|
2022
Q3 | $3.08M | Buy |
6,077
+325
| +6% | +$182K | 0.67% | 33 |
|
|
2022
Q2 | $3.13M | Sell |
5,752
-70
| -1% | -$38.5K | 0.76% | 35 |
|
|
2022
Q1 | $3.44M | Sell |
5,822
-2,327
| -29% | -$1.34M | 0.64% | 38 |
|
|
2021
Q4 | $5.44M | Buy |
8,149
+108
| +1% | +$67.4K | 0.93% | 20 |
|
|
2021
Q3 | $4.59M | Sell |
8,041
-55
| -0.7% | -$30.2K | 0.84% | 25 |
|
|
2021
Q2 | $4.08M | Buy |
8,096
+915
| +13% | +$432K | 0.77% | 32 |
|
|
2021
Q1 | $3.32M | Buy |
7,181
+307
| +4% | +$147K | 0.72% | 40 |
|
|
2020
Q4 | $3.2M | Sell |
6,874
-91
| -1% | -$42.7K | 0.77% | 34 |
|
|
2020
Q3 | $3.08M | Buy |
6,965
+120
| +2% | +$49.6K | 0.84% | 31 |
|
|
2020
Q2 | $2.48M | Buy |
6,845
+43
| +0.6% | +$14.4K | 0.73% | 39 |
|
|
2020
Q1 | $1.93M | Sell |
6,802
-748
| -10% | -$236K | 0.73% | 44 |
|
|
2019
Q4 | $2.45M | Sell |
7,550
-166
| -2% | -$50.3K | 0.76% | 37 |
|
|
2019
Q3 | $2.25M | Sell |
7,716
-193
| -2% | -$55.3K | 0.79% | 39 |
|
|
2019
Q2 | $2.32M | Sell |
7,909
-121
| -2% | -$33.3K | 0.96% | 35 |
|
|
2019
Q1 | $2.2M | Buy |
8,030
+67
| +0.8% | +$16.7K | 0.87% | 39 |
|
|
2018
Q4 | $1.78M | Sell |
7,963
-41
| -0.5% | -$9.62K | 0.86% | 42 |
|
|
2018
Q3 | $1.95M | Buy |
8,004
+297
| +4% | +$68.3K | 0.87% | 41 |
|
|
2018
Q2 | $1.6M | Buy |
7,707
+650
| +9% | +$138K | 0.81% | 55 |
|
|
2018
Q1 | $1.46M | Buy |
7,057
+267
| +4% | +$56K | 0.65% | 66 |
|
|
2017
Q4 | $1.29M | Buy |
+6,790
| New | +$1.3M | 0.67% | 63 |
|
Other funds holding TMO
RG
Slow Capital's TMO Position: Q2 2026 in Review
Slow Capital increased its Thermo Fisher Scientific (TMO) stake by 20% in Q2 2026, buying an estimated $758K and bringing the position to 9,640 shares worth $4.84M. The position accounts for 0.56% of the portfolio, ranked #64.
Slow Capital first reported a position in TMO in Q4 2017 and has held it in 35 quarters since. The position peaked at $5.44M in Q4 2021. 1,218 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Slow Capital held 9,640 shares of Thermo Fisher Scientific worth $4.84M as of Q2 2026.
- Slow Capital bought 1,579 Thermo Fisher Scientific shares in Q2 2026, an estimated $758K.
- Thermo Fisher Scientific made up 0.56% of Slow Capital's portfolio in Q2 2026, its #64 holding.
- Slow Capital first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 35 quarters since.
- Slow Capital's Thermo Fisher Scientific position peaked at $5.44M in Q4 2021.
- 1,218 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Slow Capital's 13F filing for Q2 2026, filed 22 Jul 2026.